← Back to the full Peptide Guide overview
Important Disclaimer — Read Before Using This Page
This information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide or hormone therapy. All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.
The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any therapy. Anyone starting a medication they have never taken before should take an extremely conservative approach.
Nothing on this page or in these videos should be taken as medical advice. These materials are provided only to help begin your research. All dosing and treatment decisions should be made between you and your medical providers after proper evaluation. We are not affiliated with any of the doctors whose videos appear on this page.
Semaglutide FDA-Approved
Generic for: Ozempic, Wegovy, Rybelsus
Category: GLP-1 Receptor Agonist — Weight Management & Type 2 Diabetes
How it works. Semaglutide is a long-acting analog of glucagon-like peptide-1 (GLP-1), a hormone your gut releases after you eat. It binds to GLP-1 receptors in the pancreas, gut, and brain. The result is a cascade of metabolic effects: reduced appetite and "food noise," slower stomach emptying so you feel full longer, better insulin release in response to meals, and lower fasting glucose. This is not a supplement or a wellness hack—it is a pharmacologically active medicine with real benefits and real risks.
Why a physician prescribes it. Semaglutide is FDA-approved under branded products: Ozempic for type 2 diabetes, Wegovy for chronic weight management in adults with obesity or overweight plus a weight-related comorbidity, and Rybelsus as an oral formulation for diabetes. It is particularly useful for patients whose appetite dysregulation, portion control struggles, or constant food thoughts make diet adherence nearly impossible. The clinical rationale is strongest when weight or metabolic risk is well-documented and lifestyle modification alone has not been sufficient.
What to know before starting. Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN-2. It should be used cautiously in anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, active eating disorder, or pregnancy plans. Patients on insulin or sulfonylureas need dose adjustments to avoid hypoglycemia. Rapid weight loss on any GLP-1 also means muscle loss unless you are deliberately protecting lean mass with adequate protein intake and resistance training—this is a conversation every serious prescriber has with every patient.
Recommended Videos
Dr. William Seeds — Mind Pump Show — Ozempic the Miracle Fat Loss Peptide: The Truth with Dr. William Seeds
Alila Medical Media — Semaglutide (Ozempic, Wegovy, Rybelsus) — Mechanisms of Action and Pharmacology, Animation
Dr. Sundeep Ruder, Endocrinologist — Bhekisisa Health Beat — How does semaglutide (Ozempic) work for weight loss — find out from an expert
Video Sources & Independence
The videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of mechanisms and clinical considerations. Viewers should evaluate all sources independently.
← Back to the full Peptide Guide overview · Peptide Dosing Reference →